Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 15, 10 Issues, 2015

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 29th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.469
5 - Year: 2.974

Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems

Anti-Cancer Agents in Medicinal Chemistry, 14(8): 1085-1093.

Author(s): Zhaoye Wang, Hui Sun and Juan Sebastian Yakisich.

Affiliation: Department of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden, S-141 86.


Treatment of brain tumors with chemotherapy is limited mostly because of delivery impediments related to the blood-brain barrier (BBB). For gliomas, the most common and aggressive primary brain tumor, treatment includes surgery, radiotherapy, and chemotherapy usually administered orally or intravenously. These routes do not deliver effective concentrations. To complicate matters, chemotherapy is usually a long treatment. Therefore, transient disruption of the BBB is likely insufficient to deliver effective intratumoral concentrations of anticancer drugs. This review briefly updates current strategies for overcoming the BBB with emphasis on their limitations and challenges intrinsic to the biology of cancer cells.


Anticancer drugs, blood brain barrier, brain tumor, chemotherapy, gliomas.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 8
First Page: 1085
Last Page: 1093
Page Count: 9
DOI: 10.2174/18715206113139990029

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science